project id: TCGA-READ; case submitter id: TCGA-DY-A1DD; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 77; days to birth: -28159; days to death: 1741; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1922; year of death: 2003; age at diagnosis: 28159; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1741.0; icd 10 code: C19; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 1999; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4107; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-DY-A1DD-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;